2005
DOI: 10.1159/000085749
|View full text |Cite
|
Sign up to set email alerts
|

Transurethral Microwave Thermotherapy for Treatment of Benign Prostatic Hyperplasia: A Preliminary Assessment of the Prostalund Feedback Treatment Machine

Abstract: Objective: The aim of this preliminary study was to evaluate the efficacy of Prostalund feedback treatment (PLFT) using microwave thermotherapy equipment for benign prostate hyperplasia (BPH) in patients with urinary retention and an indwelling urethral catheter. Subjects and Methods: Four unselected patients, 51–68 years old (mean age 60 years), with urinary retention and an indwelling catheter were treated with PLFT under local anaesthesia and sedation. They were considered high-risk patients for treatment b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
1
1
0
Order By: Relevance
“…There was no difference in QoL between the two groups. These results tally with other studies on high-energy TUMT [15,16].…”
Section: Discussionsupporting
confidence: 92%
“…There was no difference in QoL between the two groups. These results tally with other studies on high-energy TUMT [15,16].…”
Section: Discussionsupporting
confidence: 92%
“…Moreover, multiple interventional techniques, including microwave thermotherapy, injection of botulinum toxin, transurethral needle ablation of the prostate, neuromodulation, and extracorporeal shockwave therapy, have been utilized, with each offering varying degrees of benefit. Transrectal microwave hyperthermia of the prostate was developed as a treatment for prostate cancer [6][7][8], and its application was subsequently extended to benign prostatic hyperplasia and CP [9,10]. Transrectal prostatic hyperthermia has shown efficacy in selected patients with CP who did not respond to conventional therapies [11,12].…”
Section: Introductionmentioning
confidence: 99%